MedTrace Logo

VIVO Mapping Protocol

NCT03994068 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2019-06-21

No results posted yet for this study

Summary

This is a single centre study enrolling 15 subjects with structurally normal hearts that are already indicated for a ventricular ablation procedure (VT or PVCs).

The purpose is to compare the accuracy of VIVO and to assess its efficacy to decrease procedural time, and ideally, the procedural overall costs, as compared to standard of care ablation procedures. Results will be compared with data from

Conditions

  • Ventricular Tachycardia
  • Ventricular Ectopic Beat(S)

Interventions

DIAGNOSTIC_TEST

VIVO non invasive mapping

non invasive pre-procedural localization of PVC / VT origin

Sponsors & Collaborators

  • Royal Brompton & Harefield NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Sabine Ernst, MD, PhD · Royal Brompton and Harefield Hospital Trust

  • Ilaria Cazzoli, MD · Royal Brompton and Harefield Hospital Trust

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-30
Primary Completion
2020-01-01
Completion
2020-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03994068 on ClinicalTrials.gov